ClinicalTrials.Veeva

Menu

Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast (WALNUT)

S

SightGlass Vision

Status

Completed

Conditions

Myopia

Treatments

Device: Spectacle lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT03761758
P/639/18/SG

Details and patient eligibility

About

Prospective, randomized, subject-masked 3-arm clinical study to assess the pediatric acceptability across three iterations of a novel spectacle lens design.

Full description

This feasibility study was conducted to assess the performance of three experimental spectacle lens designs (spectacle lenses) in children between 6 and 9 years of age with myopia.

Enrollment

21 patients

Sex

All

Ages

6 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages between 6 and 12 years
  • Myopia between -1.00 and -4.00 D

Exclusion criteria

  • Participating in any clinical or other research study
  • Contact lens wearer

Trial design

Primary purpose

Device Feasibility

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

21 participants in 3 patient groups

Lens Design 1
Experimental group
Description:
Spectacle lenses design 1, fitted into spectacle frames
Treatment:
Device: Spectacle lenses
Lens Design 2
Experimental group
Description:
Spectacle lenses design 2, fitted into spectacle frames
Treatment:
Device: Spectacle lenses
Lens Design 3
Experimental group
Description:
Spectacle lenses design 3, fitted into spectacle frames
Treatment:
Device: Spectacle lenses

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems